News
12 Health Care Stocks Moving In Friday's Pre-Market Session
29 Mar 24
Movers
BioCardia: Q4 Earnings Insights
27 Mar 24
Earnings
BioCardia Q4 EPS $(0.09) Beats $(0.11) Estimate, Sales $13.00K Miss $90.00K Estimate
27 Mar 24
Earnings, News
BioCardia Ended 2023 With Cash And Cash Equivalents Of $1.1M
27 Mar 24
Earnings, News
Earnings Scheduled For March 27, 2024
27 Mar 24
Earnings
Preview: BioCardia's Earnings
26 Mar 24
Earnings
BioCardia Announced A Long-term Partnership To Advance StemCardia's Investigational Pluripotent Stem Cell Product Candidate For The Treatment Of Heart Failure
13 Mar 24
Biotech, News, Health Care, Contracts, General
Crude Oil Down Over 1%; Quoin Pharmaceuticals Shares Spike Higher
4 Mar 24
Earnings, News, Penny Stocks, Eurozone, Commodities, Global, Intraday Update, Markets, Trading Ideas
Why Bitdeer Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
4 Mar 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
12 Health Care Stocks Moving In Monday's Intraday Session
4 Mar 24
Movers
Gold Gains 1%; JOANN Shares Plummet
4 Mar 24
Earnings, News, Penny Stocks, Eurozone, Commodities, Global, Intraday Update, Markets, Trading Ideas
BioCardia Announces Activation Of CardiAMP Heart Failure II Phase 3 Pivotal Study Recently Approved By FDA
8 Feb 24
News
Press releases
BioCardia Reports Fourth Quarter and Full Year 2023 Business Highlights and Financial Results
27 Mar 24
Earnings, Press Releases
BioCardia and StemCardia Announce Biotherapeutic Delivery Partnership
13 Mar 24
Press Releases
BioCardia Announces CMS Approval of Coverage for CardiAMP Cell Therapy Confirmatory Phase III Heart Failure Study
12 Mar 24
Press Releases, General
BioCardia Reports Positive Interim Results from Phase III CardiAMP Cell Therapy Heart Failure Trial, with Compelling Data in Subgroup with Elevated NTproBNP Biomarker for Heart Failure
4 Mar 24
Health Care, Press Releases, General
BioCardia Announces Activation of CardiAMP Heart Failure II Phase 3 Pivotal Study Recently Approved by FDA
8 Feb 24
Health Care, Press Releases
BioCardia Announces Two Scientific Abstracts Have Been Accepted at the 2024 Technology and Heart Failure Therapeutics Conference
31 Jan 24
News, Health Care, Press Releases